MedTrace Logo

Mg-containing Biodegradable Polymer Bone Repair Material

NCT05758623 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2023-03-07

No results posted yet for this study

Summary

The subjects of this study are patients with non-load-bearing bone defects of the extremities who need bone grafting surgery. The patients was treated with bone graft using magnesium containing biodegradable polymer bone repair material produced by Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd.. Three follow-up visits were performed at the 12th, 24th and 36th weeks after bone grafting, the clinical role for bone will be assessed.

Conditions

  • Bone Deformity

Interventions

DEVICE

Device

The experimental group was treated with magnesium containing biodegradable polymer bone repair material produced by Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd. Control group application β- Tricalcium phosphate bioceramics for treatment.

Sponsors & Collaborators

  • Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

    collaborator OTHER

  • Chinese University of Hong Kong

    collaborator OTHER

  • Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd

    lead OTHER

Principal Investigators

  • Yuxiao Lai, Professor · Ext:+86 755 86392581 Email:[email protected] Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

  • Ling Qin, Professor · Ext:+86-755-86392258 Email:[email protected] The Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-04-30
Completion
2024-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758623 on ClinicalTrials.gov